This research 'holds promise for advancing studies on using pig livers to support or even replace human liver function,' says ...

Oxford, UK – 4 February 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces ...

Advanced hypothermic perfusion technology enabled the preservation and reallocation of a donor kidney following an unexpected late-stage decline, providing a life-saving organ to a patient in need ...

A patient with liver failure remains in stable condition two days after receiving a novel therapy using gene-edited pig liver ...

XI'AN, Feb. 5 (Xinhua) -- A Chinese research team has successfully used a gene-edited pig liver in an extracorporeal perfusion therapy to treat a patient with acute liver failure, saving the patient's ...

An anesthesiologist and a cardiologist gave up prestigious careers to save their daughter from war. Nearly four years later, ...

An anesthesiologist and a cardiologist gave up prestigious careers to save their daughter from war. Nearly four years later, they’re still on the long road to practicing their professions in the ...

RenovoRx, Inc . (“RenovoRx” or “the Company”) (Nasdaq: RNXT) , a life-sciences company developing innovative targeted ...

Johns Hopkins scientists and partners across the country are conducting research that could dramatically improve transplants, ...

This milestone reflects our ability to deliver specialized recovery, logistics, and technology support...needed to ...

(“RenovoRx” or “the Company”) (Nasdaq: RNXT) , a life-sciences company developing innovative targeted oncology therapies and ...

Cellares. Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the ...